Prognostic Value of Prediabetes for Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of 20 cohort studies involving over 63,000 patients demonstrates that prediabetes is significantly associated with an increased risk of major adverse cardiovascular events, all-cause mortality, and cardiac death in individuals with established coronary heart disease, with the magnitude of risk varying according to the specific diagnostic criteria used.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart disease remains a leading cause of death for adults around the world, carrying a heavy burden on families and economies alike. For those already living with coronary heart disease, where the arteries supplying the heart are narrowed or blocked, the primary goal is to prevent major adverse cardiovascular events. These events include heart attacks, strokes, and death. Doctors have long known that high blood sugar is dangerous, but a gray area exists between normal sugar levels and full-blown diabetes. This intermediate state, known as prediabetes, is a common condition where blood sugar is higher than normal but not yet high enough to be diagnosed as diabetes. It is a widespread issue, affecting a significant portion of the adult population globally. The critical question for medical researchers has been whether this intermediate state of prediabetes, often overlooked, actually increases the risk of serious heart complications for people who already have heart disease, and if so, how best to identify it.
To answer this, a team of researchers conducted a comprehensive review of existing scientific studies to see what the collective evidence says. They gathered data from twenty different studies involving more than sixty-three thousand patients who had been diagnosed with coronary heart disease. These studies tracked the patients over time, with a median follow-up of three years, to see who developed new heart problems or passed away. The researchers specifically looked at how the definition of prediabetes affected the results, as doctors use different sets of rules to diagnose the condition. Some rules rely on a single blood test taken after fasting, others on a measure of average blood sugar over the last few months, and some on a combination of these tests. By pooling the data from all these studies, the researchers could see a clearer picture than any single study could provide on its own.
The analysis revealed a clear and consistent pattern: patients with coronary heart disease who also had prediabetes faced a significantly higher risk of suffering a major adverse cardiovascular event compared to those with normal blood sugar levels. The risk was not just slightly higher; it was substantial enough to be statistically significant across the board. When looking at the specific outcomes, the presence of prediabetes was linked to a higher likelihood of dying from any cause, as well as a higher likelihood of dying specifically from heart-related causes. The researchers found that these risks held true regardless of whether the patients had recently suffered an acute heart event or had stable, long-standing heart disease, suggesting that the danger of prediabetes is a persistent factor in the lives of heart patients.
A key part of this investigation was understanding how the method of diagnosis influenced the findings. The researchers discovered that the way prediabetes was defined changed the estimated size of the risk. When the condition was identified using a test that measures average blood sugar over time, the risk appeared higher and more consistent across studies. When defined by a single fasting blood sugar test, the risk was still present but appeared less certain. The study suggests that the test measuring average blood sugar might be a more stable and reliable indicator of future heart trouble for these patients than the fasting test alone. This distinction is important because it implies that the specific tool doctors use to screen for prediabetes could change how they assess a patient's future risk.
Despite the strong evidence linking prediabetes to worse heart outcomes, the researchers noted some limitations in the available data. They were unable to include results from a specific type of glucose tolerance test, which involves drinking a sugary solution and waiting two hours for a blood draw, because not enough studies reported using it for this specific group of patients. This gap highlights a real-world challenge in large medical studies, as these tests can be difficult to administer and less practical for routine screening. Additionally, the studies reviewed were observational, meaning they watched what happened naturally rather than testing a new treatment, which means other unmeasured factors could still be influencing the results.
The final conclusion from this large-scale review is that prediabetes is not a harmless condition for people with heart disease; it is a significant warning sign that increases the chance of future heart attacks, strokes, and death. The study supports the idea that doctors should be more vigilant in screening for this condition in heart patients, particularly using tests that measure average blood sugar levels. By identifying and managing prediabetes early, there is a potential to lower the risk of these devastating events. The researchers emphasize that managing heart disease should include long-term attention to blood sugar levels, treating prediabetes not as a temporary state but as a critical part of a patient's ongoing health journey.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.